Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.560
0.00 (0.00%)
At close: Mar 6, 2026, 4:00 PM EST
2.650
+0.090 (3.51%)
After-hours: Mar 6, 2026, 7:36 PM EST
Century Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 460 | 86 | 199 | 303 | 867 | - | |
| Market Cap Growth | 622.22% | -56.77% | -34.34% | -65.09% | - | - | |
| Enterprise Value | 372 | -58 | 77 | -6 | 597 | - | |
| Last Close Price | 2.56 | 1.01 | 3.32 | 5.13 | 15.86 | - | |
| PS Ratio | 4.06 | 13.03 | 88.88 | 58.19 | - | - | |
| PB Ratio | 1.26 | 0.53 | 1.08 | 1.00 | 2.19 | - | |
| P/TBV Ratio | 3.24 | 0.68 | 1.08 | 1.00 | 2.19 | - | |
| P/OCF Ratio | - | - | - | 21.53 | - | - | |
| EV/Sales Ratio | 3.28 | - | 34.33 | - | - | - | |
| Debt / Equity Ratio | 0.26 | 0.33 | 0.26 | 0.16 | 0.06 | 0.29 | |
| Net Debt / Equity Ratio | -0.50 | -0.84 | -0.67 | -0.88 | -0.50 | -0.74 | |
| Net Debt / EBITDA Ratio | 8.96 | 1.11 | 1.11 | 2.31 | 2.17 | 1.13 | |
| Net Debt / FCF Ratio | 0.78 | 1.23 | 1.22 | 16.08 | 1.48 | 1.06 | |
| Asset Turnover | 0.36 | 0.02 | 0.01 | 0.01 | - | - | |
| Quick Ratio | 6.05 | 1.47 | 9.81 | 10.61 | 14.25 | 6.33 | |
| Current Ratio | 6.25 | 1.50 | 9.92 | 10.72 | 14.57 | 6.51 | |
| Return on Equity (ROE) | -14.24% | -73.14% | -56.07% | -37.46% | -40.81% | -66.45% | |
| Return on Assets (ROA) | -4.47% | -23.67% | -18.47% | -16.75% | -21.80% | -31.10% | |
| Return on Capital Employed (ROCE) | -10.20% | -60.50% | -36.50% | -27.10% | -22.50% | -51.90% | |
| Earnings Yield | -5.76% | -147.38% | -68.80% | -43.28% | -11.06% | - | |
| FCF Yield | -24.61% | -128.42% | -51.39% | -5.47% | -15.46% | - | |
| Buyback Yield / Dilution | -19.08% | -32.60% | -2.70% | -78.30% | -332.95% | -10.43% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.